Enliven Therapeutics, Inc. — Institutional Ownership
Which tracked institutions hold ELVN, and how they changed the position last quarter. Latest holdings as of Jun 30, 2026. Source: SEC 13-F filings.
24
Funds holding
$415854366
Total value held
Buying
19 added/new · 4 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Blackrock, Inc. | $221254979 | 4359704 | +674997 | +18.32% |
| 2 | State Street Corp | $61591012 | 1213616 | +122510 | +11.23% |
| 3 | Morgan Stanley | $25878866 | 509928 | -8644 | -1.67% |
| 4 | Northern Trust Corp | $22377604 | 440938 | +68622 | +18.43% |
| 5 | Ubs Group Ag | $17362337 | 342115 | +342115 | NEW BUY |
| 6 | Goldman Sachs Group Inc | $16349417 | 322156 | -150959 | -31.91% |
| 7 | Ameriprise Financial Inc | $12747995 | 251192 | +251192 | NEW BUY |
| 8 | Blackstone Inc. | $10949008 | 215744 | +215744 | NEW BUY |
| 9 | Bank Of New York Mellon Corp | $6031790 | 118853 | -1204 | -1.00% |
| 10 | Invesco Ltd. | $5733329 | 112972 | +112972 | NEW BUY |
| 11 | Bank Of America Corp /De/ | $4974667 | 98023 | +52861 | +117.05% |
| 12 | Jpmorgan Chase & Co | $2059934 | 37890 | +17070 | +81.99% |
| 13 | Wells Fargo & Company/Mn | $1983259 | 39079 | +24788 | +173.45% |
| 14 | Franklin Resources Inc | $1581522 | 31163 | +10981 | +54.41% |
| 15 | Citigroup Inc | $1558634 | 30712 | +12223 | +66.11% |
| 16 | Barclays Plc | $1056413 | 20816 | +8986 | +75.96% |
| 17 | Prudential Financial Inc | $892185 | 17580 | -49360 | -73.74% |
| 18 | Royal Bank Of Canada | $476000 | 9378 | +3954 | +72.90% |
| 19 | Janus Henderson Group Plc | $431200 | 11000 | +11000 | NEW BUY |
| 20 | Stifel Financial Corp | $263041 | 5183 | +5183 | NEW BUY |
| 21 | Sei Investments Co | $262428 | 5171 | +5171 | NEW BUY |
| 22 | Us Bancorp \De\ | $37403 | 737 | +570 | +341.32% |
| 23 | Pnc Financial Services Group, Inc. | $1117 | 22 | — | Held |
| 24 | Fifth Third Bancorp | $226 | 4 | +4 | NEW BUY |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.